EUVIMEDEUVIMED entdecken
Crossref

CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γ in Placental JEG3 Cells

Naoe Kotomura, Yohei Shimono, Satoru Ishihara iD

Endocrinology · 2024

DOI: 10.1210/endocr/bqae055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Naoe Kotomura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan. Hauptthemen laut MEDLINE: Aromatase, Placenta, Transcription Factor AP-2, RNA Stability. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CYP19A1 encodes aromatase, which converts testosterone to estrogen, and is induced during placental maturation. To elucidate the molecular mechanism underlying this function, histone methylation was analyzed using the placental cytotrophoblast cell line, JEG3. Treatment of JEG3 cells with 3-deazaneplanocin A, an inhibitor of several methyltransferases, resulted in increased CYP19A1 expression, accompanied by removal of the repressive mark H3K27me3 from the CYP19A1 promoter. However, this increase was not observed in cells treated with GSK126, another specific inhibitor for H3K27me3 methylation. Expression of TFAP2C, which encodes AP-2γ, a transcription factor that regulates CYP19A1, was also elevated on 3-deazaneplanocin A treatment. Interestingly, TFAP2C messenger RNA (mRNA) was readily degraded in JEG3 cells but protected from degradation in the presence of 3-deazaneplanocin A. TFAP2C mRNA contained N6-methyladenosines, which were reduced on drug treatment. These observations indicate that the TFAP2C mRNA undergoes adenosine methylation and rapid degradation, whereas 3-deazaneplanocin A suppresses methylation, resulting in an increase in AP-2γ levels. We conclude that the increase in AP-2γ expression via stabilization of the TFAP2C mRNA is likely to underlie the increased CYP19A1 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AromatasePlacentaTranscription Factor AP-2RNA StabilityGene Expression RegulationPromoter Regions, GeneticHumansCell LineCREB-Binding ProteinChromatinAdenosine

Stichwörter der Autor:innen

3-deazaneplanocin AH3K27acaromatasecytotrophoblasthistone methylation

Substanzen

CYP19A1 protein, humanAromataseCREB-Binding ProteinChromatinTFAP2C protein, humanTranscription Factor AP-23-deazaneplanocinAdenosine

Autor:innen und Institutionen

  • Department of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.

ORCID-Profile: Satoru Ishihara

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kotomura, N., Shimono, Y., & Ishihara, S. (2024). CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γ in Placental JEG3 Cells. Endocrinology. https://doi.org/10.1210/endocr/bqae055

Vancouver

Kotomura N, Shimono Y, Ishihara S. CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γ in Placental JEG3 Cells. Endocrinology. 2024. doi:10.1210/endocr/bqae055

BibTeX
@article{Kotomura2024,
  author = {Kotomura, Naoe and Shimono, Yohei and Ishihara, Satoru},
  title = {CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γ in Placental JEG3 Cells},
  journal = {Endocrinology},
  year = {2024},
  doi = {10.1210/endocr/bqae055}
}
Kostenlos starten →